论文部分内容阅读
RNA Therapeutics is an area of drug development that comprises a number of nucleic acid-based modalities including gene silencing by RNAi and antisense, the modulation of RNA processing, and messenger RNAs for protein expression.The combination of increased technological maturity and the explosion in the insight into disease genetics has allowed this sector to rapidly emerge as the 3rd major drug discovery engine in the pharmaceutical industry following small molecules and recombinant proteins.This presentation will discuss the promise of RNA Therapeutics, recent technological and clinical progress, and then provide an outlook on how the RNA Therapeutics revolution will likely unfold over the next 3-4 years.Some of these developments including in HBV infection and liver cancer will directly touch on diseases of high medical priority in China.